Vanguard Group’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Vanguard Group’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-160,367	Closed	-$856K	–	4509
2023 Q4	$856K	Sell	160,367 -1,018	-0.6%	-$6.28K	﹤0.01%	3883
2023 Q3	$1.29M	Hold	161,385	–	–	﹤0.01%	3743
2023 Q2	$686K	Sell	161,385 -15,568	-9%	-$88.2K	﹤0.01%	4019
2023 Q1	$997K	Buy	176,953 +614	+0.3%	+$4.67K	﹤0.01%	3922
2022 Q4	$1.46M	Buy	176,339 +15,258	+9%	+$299K	﹤0.01%	3783
2022 Q3	$5.19M	Buy	161,081 +10,359	+7%	+$384K	﹤0.01%	3304
2022 Q2	$6.06M	Buy	150,722 +114,040	+311%	+$8.33M	﹤0.01%	3268
2022 Q1	$3.92M	Sell	36,682 -27	-0.1%	-$4.23K	﹤0.01%	3643
2021 Q4	$9.15M	Buy	+36,709	New	+$8.15M	﹤0.01%	3270

Vanguard Group's SNCE Position: Q1 2024 in Review

Vanguard Group sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 160,367 shares — an estimated $856K sold.

Vanguard Group first reported a position in SNCE in Q4 2021 and held it in 9 quarters. The position peaked at $9.15M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Vanguard Group reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 160,367 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $856K.
Vanguard Group first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Vanguard Group's Science 37 Holdings, Inc. Common Stock position peaked at $9.15M in Q4 2021.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.